Open AccessAntibiotic Therapy of an Infant With a Brevibacterium casei Ventriculoperitoneal Shunt Infection
Author(s) -
Kasper Kavli Øvsthus,
Kristin Sjåvik,
Tore Lier,
Claus Klingenberg
Publication year - 2021
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000003267
Subject(s) - shunt (medical) , hydrocephalus , antibiotics , cerebrospinal fluid , vancomycin , medicine , rifampicin , microbiology and biotechnology , antibiotic therapy , surgery , biology , bacteria , staphylococcus aureus , genetics
We describe a newborn infant with hydrocephalus and a ventriculoperitoneal shunt infection caused by Brevibacterium casei. Essential for correct diagnosis was rapid species identification by matrix-assisted laser desorption/ionization time-of-flight, after initial report of coryneform bacteria. The patient responded well to vancomycin and rifampicin for 15 days. The shunt was not removed. Repeated cerebrospinal fluid cultures up to 4 months after therapy remained negative.